BIG
IRMD icon

Brooklyn Investment Group’s iRadimed IRMD Stock Holding History

Brooklyn Investment Group’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$591K Sell
6,145
-4,371
-42% -$437K 0.02% 906
2025
Q4 		$1.03M Buy
+10,516
New +$902K 0.05% 338
2025
Q2 		– Sell
-50
Closed -$2.62K – 3367
2025
Q1 		$2.62K Buy
+50
New +$2.81K ﹤0.01% 2064

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brooklyn Investment Group's IRMD Position: Q1 2026 in Review

Brooklyn Investment Group reduced its iRadimed (IRMD) stake by 42% in Q1 2026, selling an estimated $437K and leaving 6,145 shares worth $591K. The position accounts for 0.02% of the portfolio, ranked #906.

Brooklyn Investment Group first reported a position in IRMD in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.03M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Brooklyn Investment Group held 6,145 shares of iRadimed worth $591K as of Q1 2026.
  • Brooklyn Investment Group sold 4,371 iRadimed shares in Q1 2026, an estimated $437K.
  • iRadimed made up 0.02% of Brooklyn Investment Group's portfolio in Q1 2026, its #906 holding.
  • Brooklyn Investment Group first reported a position in iRadimed in Q1 2025 and has held it in 3 quarters since.
  • Brooklyn Investment Group's iRadimed position peaked at $1.03M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.